$VUZI
Vuzix Corp Stock $vuzi

$vuzi Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000114420418058336 Filed on November 08, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$1.979M	$1.923M	$1.405M
YoY Change	23.92%	36.87%	240894.85%
Cost Of Revenue	$1.680M	$1.302M	$1.497M
YoY Change	-11.58%	-13.0%	82.77%
Gross Profit	$300.0K	$621.0K	-$92.00K
YoY Change	-198.68%	-775.0%	38718.57%
Gross Profit Margin	15.16%	32.29%	-6.55%
Selling, General & Admin	$2.170M	$2.633M	$2.521M
YoY Change	-25.94%	4.42%	19.26%
% of Gross Profit	723.33%	423.98%
Research & Development	$3.220M	$2.468M	$1.506M
YoY Change	38.2%	63.87%	-30.84%
% of Gross Profit	1073.33%	397.5%
Depreciation & Amortization	$540.0K	$460.0K	$320.0K
YoY Change	100.0%	43.75%	18.52%
% of Gross Profit	180.0%	74.07%
Operating Expenses	$5.910M	$5.464M	$5.430M
YoY Change	7.07%	0.61%	26.52%
Operating Profit	-$5.610M	-$4.843M	-$5.522M
YoY Change	-3.67%	-12.31%	16.88%
Interest Expense	$60.00K	$2.937K	$12.59K
YoY Change	-200.0%	-76.68%	-62.94%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	$45.19K	$20.25K
YoY Change	-200.0%	123.15%	-106.52%
Pretax Income	-$5.560M	-$4.798M	-$5.502M
YoY Change	-5.44%	-12.8%	9.26%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.564M	-$4.798M	-$5.502M
YoY Change	-5.36%	-12.8%	109153.38%
Net Earnings / Revenue	-281.15%	-249.51%	-391.6%
Basic Earnings Per Share
Diluted Earnings Per Share	-$201.5K	-$174.5K	-$257.4K
COMMON SHARES
Basic Shares Outstanding	27.59M shares	27.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.30M	$23.50M	$8.700M
YoY Change	16.11%	170.11%	47.46%
Cash & Equivalents	$17.26M	$23.47M	$8.677M
Short-Term Investments
Other Short-Term Assets	$2.100M	$2.000M	$900.0K
YoY Change	110.0%	122.22%	-10.0%
Inventory	$7.282M	$6.803M	$2.800M
Prepaid Expenses
Receivables	$772.3K	$1.048M	$1.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.38M	$33.34M	$13.60M
YoY Change	28.91%	145.13%	22.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.292M	$4.075M	$3.900M
YoY Change	4.05%	4.49%	27.02%
Goodwill
YoY Change
Intangibles	$1.165M	$1.070M
YoY Change	43.1%
Long-Term Investments	$300.0K	$300.0K
YoY Change
Other Assets	$259.2K	$469.3K
YoY Change
Total Long-Term Assets	$7.751M	$5.839M	$4.900M
YoY Change	38.63%	19.17%	26.66%
TOTAL ASSETS
Total Short-Term Assets	$27.38M	$33.34M	$13.60M
Total Long-Term Assets	$7.751M	$5.839M	$4.900M
Total Assets	$35.13M	$39.18M	$18.50M
YoY Change	30.93%	111.77%	23.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.668M	$1.796M	$1.800M
YoY Change	-28.39%	-0.22%	17.68%
Accrued Expenses	$1.614M	$1.243M	$1.200M
YoY Change	16.14%	3.55%	13.93%
Deferred Revenue	$152.4K	$316.5K
YoY Change	107.4%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$4.677M	$3.582M	$3.300M
YoY Change	-14.25%	8.55%	-24.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.677M	$3.582M	$3.300M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.677M	$3.582M	$3.300M
YoY Change	-14.25%	8.55%	-29.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$118.3M	-$112.7M
YoY Change	22.59%
Common Stock	$27.59K	$27.56K
YoY Change	13.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.46M	$35.60M	$15.20M
YoY Change
Total Liabilities & Shareholders Equity	$35.13M	$39.18M	$18.50M
YoY Change	30.93%	111.77%	23.59%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$5.564M	-$4.798M	-$5.502M
YoY Change	-5.36%	-12.8%	109153.38%
Depreciation, Depletion And Amortization	$540.0K	$460.0K	$320.0K
YoY Change	100.0%	43.75%	18.52%
Cash From Operating Activities	-$4.610M	-$5.180M	-$4.540M
YoY Change	5.25%	14.1%	24.38%
INVESTING ACTIVITIES
Capital Expenditures	-$1.850M	-$500.0K	-$820.0K
YoY Change	83.17%	-39.02%	7.89%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$1.600M	-$500.0K	-$820.0K
YoY Change	58.42%	-39.02%	7.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$7.978M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	7.920M
YoY Change	-100.0%	-100.0%	37.26%
NET CHANGE
Cash From Operating Activities	-4.610M	-5.180M	-4.540M
Cash From Investing Activities	-1.600M	-500.0K	-820.0K
Cash From Financing Activities	0.000	0.000	7.920M
Net Change In Cash	-6.210M	-5.680M	2.560M
YoY Change	-200.16%	-321.88%	88.24%
FREE CASH FLOW
Cash From Operating Activities	-$4.610M	-$5.180M	-$4.540M
Capital Expenditures	-$1.850M	-$500.0K	-$820.0K
Free Cash Flow	-$2.760M	-$4.680M	-$3.720M
YoY Change	-18.1%	25.81%	28.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	81724	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23471941	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14889636	USD
CY2018Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	675459	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1047659	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	974172	USD
CY2018Q3	vuzi	Accrued Revenuecurrent AccruedRevenuecurrent	0	USD
CY2017Q4	vuzi	Accrued Revenuecurrent AccruedRevenuecurrent	497784	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	6802593	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	3852317	USD
CY2018Q3	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	513714	USD
CY2017Q4	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	154717	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1501951	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	873947	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	33337858	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	21242573	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4075176	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4124466	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1069954	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	813774	USD
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	196769	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	107824	USD
CY2018Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	152927	USD
CY2018Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30280	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3500	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3582191	USD
CY2018Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	225000	USD
CY2017Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	408723	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	469316	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	243717	USD
CY2018Q3	us-gaap	Assets Assets	39177304	USD
CY2017Q4	us-gaap	Assets Assets	26833253	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1796062	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3726056	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	316460	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	73462	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5453540	USD
CY2018Q3	us-gaap	Liabilities Liabilities	3582191	USD
CY2017Q4	us-gaap	Liabilities Liabilities	5453540	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	50	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	50	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	27564	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	24276	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	148270081	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	117827839	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112702582	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	35595113	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39177304	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26833253	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	81724	USD
CY2018Q1	us-gaap	Deferred Revenue DeferredRevenue	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96472452	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96390728	USD
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	49626	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	49626	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	49626	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	49626	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27564509	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27564509	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24276275	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24276275	shares
CY2017Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	1669209	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18574	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	25090	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3990662	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2994342	USD
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	21379713	USD
	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	81724	USD
	vuzi	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	39376	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1194754	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30000000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	228000	USD
	us-gaap	Revenues Revenues	6114877	USD
	us-gaap	Revenues Revenues	3941025	USD
CY2018Q3	us-gaap	Revenues Revenues	1923400	USD
CY2017Q3	us-gaap	Revenues Revenues	1405100	USD
	vuzi	Revenue Performance Obligation Percentage RevenuePerformanceObligationPercentage	1	pure
	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	8,615,525
	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	6,532,259
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	1302480	USD
CY2018Q3	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	3468816	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	836324	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4842950	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5522495	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7158356	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	50000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	100000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	175260	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13873	USD
CY2018Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	628130	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	163305	USD
CY2018Q3	vuzi	Accrued Compensation AccruedCompensation	0	USD
CY2017Q4	vuzi	Accrued Compensation AccruedCompensation	327469	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	226348	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	531728	USD
CY2018Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	280852	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	167503	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20833	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	28331	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1242620	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1389771	USD
CY2018Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	86457	USD
CY2017Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	171435	USD
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	167503	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	259905	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	373254	USD
CY2018Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	280852	USD
CY2018Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	USD
CY2018Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0	USD
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	152927	USD
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	152927	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	152927	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	13873	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1975000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	1497101	USD
	us-gaap	Cost Of Revenue CostOfRevenue	4646660	USD
	us-gaap	Cost Of Revenue CostOfRevenue	4313787	USD
	us-gaap	Gross Profit GrossProfit	1468217	USD
	us-gaap	Gross Profit GrossProfit	-372762	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	620920	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	-92001	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4374202	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2468449	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1506307	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4048029	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2739978	USD
CY2018Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	966294	USD
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	908797	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5579500	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4155960	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1666596	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1612542	USD
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	377724	USD
CY2017Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	251366	USD
	us-gaap	Operating Expenses OperatingExpenses	17717027	USD
	us-gaap	Operating Expenses OperatingExpenses	13155797	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	5463870	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	5430494	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16248810	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13528559	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	111075	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	45800	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	71089	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	12956	USD
	us-gaap	Taxes Other TaxesOther	47667	USD
	us-gaap	Taxes Other TaxesOther	37884	USD
CY2018Q3	us-gaap	Taxes Other TaxesOther	17809	USD
CY2017Q3	us-gaap	Taxes Other TaxesOther	15734	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-36615	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-30299	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-26963	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5246	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-13873	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	50598	USD
CY2018Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	21814	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	175260	USD
	us-gaap	Interest Expense InterestExpense	19128	USD
	us-gaap	Interest Expense InterestExpense	77849	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-63044	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-225479	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16311854	USD
CY2017Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	41454	USD
CY2018Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2017Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	2937	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	12592	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	45194	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20253	USD
CY2018Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2017Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-585	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-56836	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-585	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13754038	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1351147	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1273029	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17663001	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15027067	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4797756	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5502242	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4797756	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-5502242	USD
CY2018Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	462034	USD
CY2017Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	435321	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5259790	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5937563	USD
	us-gaap	Net Income Loss NetIncomeLoss	-16311854	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13754038	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	946335	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	734175	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	75000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	214838	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1473383	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	50598	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	73487	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	367170	USD
	vuzi	Increasedecrease In Accrued Revenue IncreasedecreaseInAccruedRevenue	-497784	USD
	vuzi	Increasedecrease In Accrued Revenue IncreasedecreaseInAccruedRevenue	687001	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2950276	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	242998	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1342855	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-159351	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	912102	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2573	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2018Q3	us-gaap	Share Based Compensation ShareBasedCompensation	291000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	425000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	442185	USD
	vuzi	Increase Decrease In Unearned Revenue IncreaseDecreaseInUnearnedRevenue	88945	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-285980	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1718578	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	734478	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-66371	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	253398	USD
	vuzi	Increase Decrease In Unearned Revenue IncreaseDecreaseInUnearnedRevenue	-392242	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	26779	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5626	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-327469	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-240110	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	39687	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	77537	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17934510	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12091984	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	886713	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1197452	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	323347	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	155284	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	87500	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	329204	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1547560	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1681940	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	39375	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8567500	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1975000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	650179	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28064375	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7917321	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8582305	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5856603	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14533944	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8677341	USD
	us-gaap	Interest Paid Net InterestPaidNet	104105	USD
	us-gaap	Interest Paid Net InterestPaidNet	310	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1861283	USD
	vuzi	Cumulative Revenue Adjustment CumulativeRevenueAdjustment	81724	USD
	vuzi	Cumulative Revenue Adjustment CumulativeRevenueAdjustment	0	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	38100	shares
CY2018Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	6200210	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4849063	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1184912	shares
	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	113850	shares
	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	1200000	shares
	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	8000	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2263062	shares
	vuzi	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms	P1Y4M28D
	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	8.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	924309	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	465554	shares
	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y9M18D
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2410000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	382702	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	7632	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8904	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	951969	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	110546	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	349168	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	344227	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	117372	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	115718	USD
	vuzi	Increase Decrease In Manufacturing Vendors Prepayments IncreaseDecreaseInManufacturingVendorsPrepayments	358997	USD
	vuzi	Increase Decrease In Manufacturing Vendors Prepayments IncreaseDecreaseInManufacturingVendorsPrepayments	-26644	USD
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.88
CY2018Q3	vuzi	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Nonvested In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedInPeriodFairValue	310000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.65
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27504626	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21366712	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27046913	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20515363	shares
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="background: white; margin: 0px 0px 0px 0in; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Note 1 – Basis of Presentation</div></div></div><div style="background: none; margin: 0px 0px 0px 34.55pt; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-size: 10pt; text-decoration: none; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements of Vuzix Corporation (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (the “SEC”). </div><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accordingly, the unaudited condensed consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Certain re-classifications have been made to prior periods to conform with current reporting. The results of the Company’s operations for the nine months ended September 30, 2018 are not necessarily indicative of the results of the Company’s operations for the full fiscal year or any other period.</div></div><div style="margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt; background: none;"><div style="font-size: 10pt; text-decoration: none; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto of the Company as of December 31, 2017, as reported in the Company’s Annual Report </div>on Form 10-K filed with the SEC on March 16, 2018.</div><div style="margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt; background: none;"><div style="font-size: 10pt; text-decoration: none; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: white; margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2018, Toshiba Japan represented 67% of </div>the Company’s<div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> engineering revenues and 27% of </div>the Company’s <div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">total revenues as compared to approximately 98% and 24% in the comparable 2017 period. As of September 30, 2018 and 2017, Toshiba Japan accounted for 1% and 0% of </div>the Company’s <div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">accounts </div> receivables and 0% and 59% of the Company’s accrued <div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> project revenue, respectively.</div></div><div style="margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt; background: none;"><div style="font-size: 10pt; text-decoration: none; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="background: white; margin: 0px 0px 0px 0in; text-indent: 0.5in; font-family: "times new roman", times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2018, AMA SA represented 14% of </div>the Company’s <div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">total revenues as compared to 8% in the comparable 2017 period. As of September 30, 2018 and 2017, AMA SA accounted for 0% and 6% of </div>the Company’s <div style="font-size: 10pt; font-family: "times new roman", times, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">accounts receivables, respectively.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-56836	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	250000	USD
	vuzi	Unamortized On Senior Convertible Debt Attributed To Embedded Conversion Price Adjustment Option UnamortizedOnSeniorConvertibleDebtAttributedToEmbeddedConversionPriceAdjustmentOption	166800	USD
	vuzi	Accrued Stock Based Compensation Expense AccruedStockBasedCompensationExpense	313129	USD
	vuzi	Accrued Stock Based Compensation Expense AccruedStockBasedCompensationExpense	0	USD
CY2018Q3	us-gaap	Cost Method Investments Original Cost CostMethodInvestmentsOriginalCost	250000	USD
CY2017Q4	us-gaap	Cost Method Investments Original Cost CostMethodInvestmentsOriginalCost	0	USD
CY2018Q2	vuzi	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.01	pure
CY2018Q2	vuzi	Cost Method Investment Additional Ownership Percentage CostMethodInvestmentAdditionalOwnershipPercentage	0.04	pure
	vuzi	Fair Value Measurement With Unobservable Inputs Reclassification Of Warrant Exercises To Additional Paid In Capital FairValueMeasurementWithUnobservableInputsReclassificationOfWarrantExercisesToAdditionalPaidInCapital	-166800	USD
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	100000	shares
CY2018Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.10
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	610000	USD
	vuzi	Aggregate Fair Market Value Of Sock Awards AggregateFairMarketValueOfSockAwards	122000	USD
	vuzi	Common Stock Awards Compensation Expense CommonStockAwardsCompensationExpense	216744	USD
	vuzi	Common Stock Awards Compensation Expense CommonStockAwardsCompensationExpense	83750	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-585	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-211416	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1151482	USD
	us-gaap	Increase Decrease In Due From Officers And Stockholders Current IncreaseDecreaseInDueFromOfficersAndStockholdersCurrent	0	USD
	us-gaap	Increase Decrease In Due From Officers And Stockholders Current IncreaseDecreaseInDueFromOfficersAndStockholdersCurrent	61000	USD
	vuzi	Unamortized On Senior Convertible Debt Attributed To Embedded Conversion Price Adjustment Option UnamortizedOnSeniorConvertibleDebtAttributedToEmbeddedConversionPriceAdjustmentOption	0	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	USD
	vuzi	Onetime Compensation Expense OnetimeCompensationExpense	384000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2017	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	166800	USD
CY2018Q3	vuzi	Gain Loss On Inventory Revaluation And Product Discontinuance GainLossOnInventoryRevaluationAndProductDiscontinuance	211416	USD
CY2017Q3	vuzi	Gain Loss On Inventory Revaluation And Product Discontinuance GainLossOnInventoryRevaluationAndProductDiscontinuance	-1151482	USD
	vuzi	Gain Loss On Inventory Revaluation And Product Discontinuance GainLossOnInventoryRevaluationAndProductDiscontinuance	211416	USD
	vuzi	Gain Loss On Inventory Revaluation And Product Discontinuance GainLossOnInventoryRevaluationAndProductDiscontinuance	-1151482	USD
CY2015Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price). The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations.
CY2018Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	196223	USD
CY2017Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	196223	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	vuzi	Reclassification Of Unamortized Stock Compensation Expense Included In Prepaid Expenses ReclassificationOfUnamortizedStockCompensationExpenseIncludedInPrepaidExpenses	740000	USD
	vuzi	Reclassification Of Unamortized Stock Compensation Expense Included In Prepaid Expenses ReclassificationOfUnamortizedStockCompensationExpenseIncludedInPrepaidExpenses	301250	USD
	vuzi	Aggregate Fair Market Value Of Sock Awards1 AggregateFairMarketValueOfSockAwards1	488000	USD
CY2018Q2	us-gaap	Cost Method Investments Original Cost CostMethodInvestmentsOriginalCost	250000	USD
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	80000000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	Vuzix Corp
	dei	Entity Central Index Key EntityCentralIndexKey	0001463972
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	VUZI
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27587502	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false

Files In Submission

Name	View Source	Status
0001144204-18-058336-index-headers.html	Edgar Link	pending
0001144204-18-058336-index.html	Edgar Link	pending
0001144204-18-058336.txt	Edgar Link	pending
0001144204-18-058336-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv505981_10q.htm	Edgar Link	pending
tv505981_ex31-1.htm	Edgar Link	pending
tv505981_ex31-2.htm	Edgar Link	pending
tv505981_ex32-1.htm	Edgar Link	pending
tv505981_ex32-2.htm	Edgar Link	pending
vuzi-20180930.xml	Edgar Link	completed
vuzi-20180930.xsd	Edgar Link	pending
vuzi-20180930_cal.xml	Edgar Link	unprocessable
vuzi-20180930_def.xml	Edgar Link	unprocessable
vuzi-20180930_lab.xml	Edgar Link	unprocessable
vuzi-20180930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VUZI
Vuzix Corp Stock $vuzi

2018 Q4 Form 10-Q Financial Statement

#000114420418058336 Filed on November 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI Vuzix Corp Stock $vuzi

2018 Q4 Form 10-Q Financial Statement

#000114420418058336 Filed on November 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI
Vuzix Corp Stock $vuzi